1. Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments;Arnerić;Biochemical Pharmacology [Internet],2018
2. Beaton D, Maxell L, Grosskleg S, Shea B, Tugwell P. The OMERACT Handbook [Internet]. 2021. Available from: https://omeract.org/handbook/.
3. Proposal for Standardization of Clinical Outcomes Assessment Strategies for Early-Stage Drug Development Trials;Bishop;Innov Clin Neurosci,2023
4. COMET-Initiative. COMET-Initiative. 2017. COMET Proect 606. Available from: https://www.comet-initiative.org/Studies/Details/606.
5. ECNP COA Group. Clinical Outcomes Assessment Selection - Practical Guidance in Neuroscience Drug Development. V3 [Internet]. 2023. Available from: https://drive.google.com/file/d/10NRU1eIyGnMwCZgEfMqDUbwc9o0HqOG1/view?usp=drive_link.